Transformative Biotech Formed to Deploy
Transformative Direct-to-PCR technologies
Transformative Biotech created to deploy direct-to-PCR technologies in the fields of molecular diagnostics of infectious diseases and cancer, and biotechnology research
Boulder, Colo., January 29, 2023 – – Transformative Biotech announced today the formation of the company focused on deploying transformative, direct-to-PCR technologies in the fields of molecular diagnostics of infectious diseases and cancer; and biotechnology research.
“We are excited by the potential of the company’s rapid, highly accurate, direct-to-PCR technologies to enable rapid, highly accurate testing for infectious diseases and cancer,” said Russ Hullet, CEO. “Having been proven in the clinic during the COVID-19 pandemic, we believe the company’s direct-to-PCR technologies have the power to transform how and where molecular testing for infectious diseases and cancer is performed in the future.”
About Transformative Biotech
Transformative Biotech is a startup biotechnology company focused on deploying rapid, highly accurate, direct-to-PCR technologies with the power to transform molecular testing for infectious diseases and cancer.
Transformative Biotech Contact:
Russ Hullet, Chief Executive Officer
e: russ@transformative-bio.com
